PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies - Normandie Université Access content directly
Journal Articles Cancers Year : 2017

PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

Ahmad Najem
  • Function : Author
Sven Saussez
  • Function : Author
  • PersonId : 910399
Fabrice Journe
  • Function : Author
  • PersonId : 869723
Mohammad Krayem
  • Function : Author

Domains

Cancer

Dates and versions

hal-02362393 , version 1 (13-11-2019)

Identifiers

Cite

Anne Perdrix, Ahmad Najem, Sven Saussez, Ahmad Awada, Fabrice Journe, et al.. PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies. Cancers, 2017, 9 (12), pp.172. ⟨10.3390/cancers9120172⟩. ⟨hal-02362393⟩
18 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More